We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Core Vct I | LSE:CR. | London | Ordinary Share | GB00B03FH337 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 72.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
06/4/2017 12:56 | Kibo on the up. | peter138 | |
06/4/2017 12:28 | MTFB v active today Cheshire Man - 04 Apr 2017 - 09:50 - 989 of 991 - 0Broker Forecast- finnCap issues a broker note on Motif Bio Plc Ord 1p04 April 2017finnCap today initiates coverage of Motif Bio Plc Ord 1p (LON:MTFB) with a buy investment rating and price target of 125p.Story provided by StockMarketWire.comD | amazon_woman | |
06/4/2017 12:05 | Never would trust a Bender myself Intensity’s Chief Executive Officer Lewis H. Bender explained, “The direct killing action and immune response data generated in rodent models from our lead drug INT230-6 are impressive. We hope these animal results translate into an equally potent response in our clinical study, IT-01 for INT230-6, which is now recruiting patients in both the U.S. and Canada. Should the protective T cell immunity occur in humans, then INT230-6 could represent an important advance in the treatment of certain solid tumor cancers, potentially providing oncologists with a less toxic means to destroy visible tumors, eliminate metastases and prevent disease recurrence.” | the stigologist | |
06/4/2017 12:04 | ? Edit, found it on the Urban Dictionary... | nicosevos | |
06/4/2017 12:03 | SALV maybe onto something WESTPORT, Conn.--(BUSINESS WIRE)--Intensity Therapeutics, Inc., a privately held biotechnology company developing proprietary immune cell-activating cancer treatments, announced that tumor regression and immune activation data generated by the Company’s lead drug, INT230-6, will be presented in a poster session at the American Academy of Cancer Research (AACR) meeting on April 5, 2017. The research being presented indicates that INT230-6 results in complete response of tumors in rodent models, induces protective T cell immunity and is synergistic with checkpoint inhibitors. Dr. Anja Bloom from the Vaccine Branch of the National Cancer Institute (NCI) and Lewis H. Bender, CEO of Intensity Therapeutics will present the poster presentation. | the stigologist | |
06/4/2017 12:03 | Nick, yes I also noticed the steady upticking since end March. Not huge each day, but steady. gl f | fillipe | |
06/4/2017 11:52 | MTFB moving? | nick rubens | |
06/4/2017 11:45 | LEG KEEP AN EYE LEG 0.25 Reason: take a look at the LEG chart for starters....then read the "market whispers". | cpap man | |
06/4/2017 11:44 | Lee, Conor McGregor, he's looking tired?? | nicosevos | |
06/4/2017 11:43 | KENV + 12.5% today.... nice to see that uptick. f | fillipe | |
06/4/2017 11:27 | Yup you know me so well. AAOG holding since IPO HYR holding since last week and bought more this morning HUR holding since news last week and added on the dips Funny how hatey takes the high ground but yet is the most shocking person on this site. ADSS ramped to high heaven MRS ramped to high heaven, unforeseen what happened but before suspension you knew a placing was coming at a discount yet continued to ramp it. The list goes on. Hateys personality is the outcome of years and years of losing money. I feel sorry for you. I say it time and time again the market is not the place for you go work in Tesco or something. Filtered until you make a new account haha *facepalm* | ileeman | |
06/4/2017 11:22 | ha ha sorry if the truth hurts Lee, just try and be a bit more honest with your trades. | tradermick1 | |
06/4/2017 11:15 | Give it a rest mate your boring. Get a life. | ileeman | |
06/4/2017 11:14 | iLeeman What you say something is worth and what you sell it for is two different things. A token 4p HYR is worth post then selling for around 2.5-2.6p is sort of misleading people on this thread. But hey ho you are hardly in the league of pump and dump scum like falia and AW ! | tradermick1 | |
06/4/2017 10:57 | HYR Easily worth over 4p, just read previous RNS. AAOG My longer term hold think it will be worth multiples in a few months. HUR Looking for closer to 70p over coming weeks | ileeman | |
06/4/2017 10:53 | Tossinfo's sheep followers check their portfolios after his latest 'hot tip' | the stigologist | |
06/4/2017 10:41 | Avoid FBT hugely overvalued; lots of Management leaving/sacked (some were paying their wives for 'services') mind boggles | the stigologist | |
06/4/2017 10:15 | looks like lots of fresh money coming in from new ISA to PROX | nash81 | |
06/4/2017 09:50 | ELA - quite some trades activity at Eland this morning! CASP - very interesting - and going forward. f | fillipe | |
06/4/2017 09:36 | Good morning all CLNR which has been drifting for a while has suddenly come to life. I hold so dyor but gas field farm out discussions possibly making progress? | maytrees | |
06/4/2017 09:31 | RedstoneConnect PLC Contract Extension for OneSpaceT with UBMSource: RNS Non-RegulatoryTIDMRE | amazon_woman | |
06/4/2017 09:28 | grph looking strong to me...... | barnetpeter |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions